Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]

Scandinavian Biopharma Announces Successful Completion of Pediatric Phase IIb Trial for ETVAX® Vaccine in The Gambia

Scandinavian Biopharma is pleased to announce the successful completion of its large pediatric Phase IIb trial for ETVAX®, a promising vaccine candidate against enterotoxigenic Escherichia coli (ETEC), commonly called traveler’s diarrhea, con[...]

Scandinavian Biopharma signs a joint procurement with EU commission to supply diphtheria antitoxin

Scandinavian Biopharma and The European Commission’s Health Emergency Preparedness and Response Authority (HERA) has signed a joint procurement framework contract for the supply of diphtheria antitoxin. Eight Member States are participating in[...]